Aridis Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Aridis Pharmaceuticals Inc (Aridis) is a biopharmaceutical companythat focusses on development of novel, differentiated therapies for infectious diseases. The companys pipeline product uses disruptive platform technology to discover potent human monoclonal antibodies from patients.Its proprietary platform, MabIgXis used to discover potent therapeutic antibodies for any diseases and to generate an unrivaled product portfolio ofanti-infective mAbs. The company also works on macromolecular stabilization technology for increase the stability of vaccines. Aridis is headquartered in San Jose, California, the US.

Aridis Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Aridis Pharma Acquires Monoclonal Antibody Products And Technologies From Kenta Biotech 11
Venture Financing 13
Aridis Pharma Raises USD13.6 Million in Venture Financing 13
Aridis Pharma Raises USD15.2 Million in Financing Round 14
Aridis Pharma Raises USD3 Million Financing 15
Partnerships 16
Aridis Pharma Forms Joint Venture with Hepalink 16
GlaxoSmithKline Biologicals Enters into Option Agreement with Aridis Pharma 17
Aridis Pharma Enters Into Co-Development Agreement For Vaccine Formulation 18
Licensing Agreements 19
Aridis Pharma Enters into Licensing Agreement with University of Chicago 19
Equity Offering 20
Aridis Pharma Prices IPO of Shares for USD26 Million 20
Aridis Pharma Raises USD6.75 Million in Private Placement of Shares 22
Aridis Pharmaceuticals Inc - Key Competitors 23
Aridis Pharmaceuticals Inc - Key Employees 24
Aridis Pharmaceuticals Inc - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 25
Recent Developments 26
Corporate Communications 26
Mar 05, 2018: Aridis Pharmaceuticals Announces Management Team Changes 26
Product News 27
01/09/2017: Aridis Pharmaceuticals Receives Award from the Cystic Fibrosis Foundation Therapeutics to Advance Panaecin 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List Of Tables


Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aridis Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Aridis Pharma Acquires Monoclonal Antibody Products And Technologies From Kenta Biotech 11
Aridis Pharma Raises USD13.6 Million in Venture Financing 13
Aridis Pharma Raises USD15.2 Million in Financing Round 14
Aridis Pharma Raises USD3 Million Financing 15
Aridis Pharma Forms Joint Venture with Hepalink 16
GlaxoSmithKline Biologicals Enters into Option Agreement with Aridis Pharma 17
Aridis Pharma Enters Into Co-Development Agreement For Vaccine Formulation 18
Aridis Pharma Enters into Licensing Agreement with University of Chicago 19
Aridis Pharma Prices IPO of Shares for USD26 Million 20
Aridis Pharma Raises USD6.75 Million in Private Placement of Shares 22
Aridis Pharmaceuticals Inc, Key Competitors 23
Aridis Pharmaceuticals Inc, Key Employees 24
Aridis Pharmaceuticals Inc, Joint Venture 25

List Of Figures


Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aridis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Aridis Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Aridis Pharmaceuticals Inc (Aridis) is a biopharmaceutical companythat focusses on development of novel, differentiated therapies for infectious diseases. The companys pipeline product uses disruptive platform technology to discover potent human

USD 250 View Report

Aridis Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Aridis Pharmaceuticals LLC (Aridis) is a biotechnology company that utilizes proprietary technologies for producing anti-infectives and vaccines for infectious diseases. The companys human monoclonal antibody discovery platform technology MabIgX is

USD 250 View Report

EyePoint Pharmaceuticals Inc (PSDV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert

USD 250 View Report

EyePoint Pharmaceuticals Inc (PSDV) - Medical Equipment - Deals and Alliances Profile

EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available